Since the global impairment of mature miRNAs is emerging as a common feature of human tumors (Melo et al., 2010), and given the critical functions of Drosha, DGCR8, Exportin-5, Ran, and Dicer in miRNA biogenesis, it is logical to presume that genetic polymorphisms in these genes may affect the processing of miRNAs and, thus, cancer risk. The gene discussed is DROSHA; the disease is cancer.